NUMMULAR ECZEMA

Clinical trials for NUMMULAR ECZEMA explained in plain language.

Never miss a new study

Get alerted when new NUMMULAR ECZEMA trials appear

Sign up with your email to follow new studies for NUMMULAR ECZEMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 1

Could an existing eczema drug help a rare skin condition?

Disease control Ongoing

This Phase 2 trial tests dupilumab (Dupixent), an injectable drug already approved for atopic dermatitis, in 70 adults with nummular eczema, a chronic, itchy skin condition. Participants receive either dupilumab or a placebo for several weeks. The study measures changes in eczema…

Matched conditions: NUMMULAR ECZEMA

Phase: PHASE2 • Sponsor: Technical University of Munich • Aim: Disease control

Last updated Jun 27, 2026 07:51 UTC

NUMMULAR ECZEMA

Get alerted when new NUMMULAR ECZEMA trials appear

Could an existing eczema drug help a rare skin condition?